NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge

Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP + -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP + -induced neuronal apopto...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular neuroscience Vol. 71; no. 2; pp. 369 - 378
Main Authors Sun, Qiang, Zhang, Yueliang, Wang, Songlin, Yang, Fang, Cai, Hongxia, Xing, Yu, Chen, Zengfeng, Chen, Jun
Format Journal Article
LanguageEnglish
Published New York Springer US 01.02.2021
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0895-8696
1559-1166
1559-1166
DOI10.1007/s12031-020-01660-2

Cover

Loading…
Abstract Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP + -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP + -induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP + -induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP + -induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP + -induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.
AbstractList Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.
Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.
Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP -induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP -induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP -induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP -induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.
Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP + -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP + -induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP + -induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP + -induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP + -induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.
Author Xing, Yu
Chen, Zengfeng
Zhang, Yueliang
Cai, Hongxia
Chen, Jun
Sun, Qiang
Wang, Songlin
Yang, Fang
Author_xml – sequence: 1
  givenname: Qiang
  surname: Sun
  fullname: Sun, Qiang
  organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine
– sequence: 2
  givenname: Yueliang
  surname: Zhang
  fullname: Zhang, Yueliang
  organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine
– sequence: 3
  givenname: Songlin
  surname: Wang
  fullname: Wang, Songlin
  organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine
– sequence: 4
  givenname: Fang
  surname: Yang
  fullname: Yang, Fang
  organization: Department of Oncology, TaiHe Hospital, Hubei University of Medicine
– sequence: 5
  givenname: Hongxia
  surname: Cai
  fullname: Cai, Hongxia
  organization: Department of Obstetrics and Gynecology, TaiHe Hospital, Hubei University of Medicine
– sequence: 6
  givenname: Yu
  surname: Xing
  fullname: Xing, Yu
  organization: Department of Medical Image Center, TaiHe Hospital, Hubei University of Medicine
– sequence: 7
  givenname: Zengfeng
  surname: Chen
  fullname: Chen, Zengfeng
  organization: Chronic Disease Rehabilitation Centre 1, TaiHe Hospital, Hubei University of Medicine
– sequence: 8
  givenname: Jun
  orcidid: 0000-0002-8257-0837
  surname: Chen
  fullname: Chen, Jun
  email: drcj2019@163.com
  organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32712773$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1uFDEQhC0URDaBF-CALHHhYui2Z8Yzx1USfqQIIhKuWN6xZ-Wwaw_uGSRueY28Hk-Cl02ElENOrZa-KpWqjthBTNEz9hLhLQLod4QSFAqQIACbBoR8whZY153A8h6wBbRdLdqmaw7ZEdE1gMQK22fsUEmNUmu1YN8_ny2vkJ_6PntLIa755TyO2RN54hc2_wiRUvxzc0v8NFBBPL_Iab0DQor8V7B82U87nSW-DV8FKkChRn45prj2z9nTwW7Iv7i7x-zb-7Ork4_i_MuHTyfLc9ErXU-is2jdsJKqaxvXO4mrTrtm8LJuwHV-0M7VCl2B-lW5rh4sVq2GQXlVOZDqmL3Z-445_Zw9TWYbqPebjY0-zWRkJXUtVVtBQV8_QK_TnGNJVyjdKC1LjEK9uqPm1dY7M-awtfm3uW-uAO0e6HMiyn4wfZjsVEqZsg0bg2B2I5n9SKaMZP6NZHZh5QPpvfujIrUXUYFLs_l_7EdUfwHpR6KS
CitedBy_id crossref_primary_10_1016_j_bbadis_2024_167454
crossref_primary_10_3390_ijms21249500
crossref_primary_10_2174_1381612828666220922110551
crossref_primary_10_1002_iid3_817
crossref_primary_10_1007_s12264_023_01023_y
crossref_primary_10_3390_ijms25116146
crossref_primary_10_1186_s13018_023_04511_z
crossref_primary_10_1016_j_exger_2024_112436
crossref_primary_10_3389_fncel_2023_1044634
crossref_primary_10_1016_j_wneu_2021_08_147
crossref_primary_10_3390_ijms22189839
crossref_primary_10_1007_s00702_022_02479_4
crossref_primary_10_3390_antiox13050606
crossref_primary_10_3389_fnmol_2021_685143
crossref_primary_10_2174_1874609815666220126095847
crossref_primary_10_4103_1673_5374_358615
crossref_primary_10_1080_21655979_2022_2062989
crossref_primary_10_1007_s12035_023_03809_7
crossref_primary_10_1007_s12035_023_03849_z
crossref_primary_10_1016_j_arr_2023_101878
crossref_primary_10_18632_aging_206028
crossref_primary_10_1093_nar_gkaf074
crossref_primary_10_2147_DMSO_S355783
crossref_primary_10_3389_fnagi_2021_650840
crossref_primary_10_3390_brainsci13010150
crossref_primary_10_3390_ph15070811
crossref_primary_10_2147_JIR_S338162
crossref_primary_10_3233_JPD_202374
Cites_doi 10.1002/1878-0261.12404
10.1016/j.brainres.2020.146672
10.1093/nar/gkz621
10.1016/j.neulet.2019.134340
10.1261/rna.071456.119
10.1177/1073858417748875
10.1007/s00415-016-8213-1
10.1111/acel.13115
10.1002/mds.27874
10.1016/j.bbrc.2017.12.149
10.1016/j.yexcr.2019.111614
10.1001/jamaneurol.2017.3517
10.1042/BJ20150617
10.1007/s00018-019-03074-9
10.1001/jamaneurol.2018.1487
10.1002/mds.27602
10.1016/j.ejphar.2020.173056
10.1126/scitranslmed.aah4066
10.1096/fj.201900830R
10.1007/s00401-019-02007-x
10.1186/s13024-016-0094-3
10.1080/21691401.2019.1636805
10.1016/j.cbi.2019.04.017
10.1007/s00018-020-03503-0
10.1111/cpr.12329
10.1007/s10620-019-06020-8
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2020
Springer Science+Business Media, LLC, part of Springer Nature 2020.
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020
– notice: Springer Science+Business Media, LLC, part of Springer Nature 2020.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QR
7T7
7TK
7U9
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
K9.
M0S
M1P
M2M
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1007/s12031-020-01660-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Psychology Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Psychology
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1559-1166
EndPage 378
ExternalDocumentID 32712773
10_1007_s12031_020_01660_2
Genre Journal Article
GrantInformation_xml – fundername: Science and Technology Research Development plan project of Shaanxi Province
  grantid: No.2010R034-2
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VX
0VY
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3SX
3V.
4.4
406
408
40D
40E
44B
53G
5GY
5RE
5VS
67N
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACCUX
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
H13
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
ITM
IWAJR
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M1P
M2M
M4Y
MA-
MVM
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QR
7T7
7TK
7U9
7XB
8FD
8FK
ABRTQ
C1K
FR3
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c375t-9a1adfb23986dcd21b97d6fe2560d9ef7dd531d1adcb31dd5fa14870f3e34d023
IEDL.DBID U2A
ISSN 0895-8696
1559-1166
IngestDate Mon Jul 21 10:47:35 EDT 2025
Fri Jul 25 23:50:20 EDT 2025
Thu Apr 03 07:05:44 EDT 2025
Thu Apr 24 23:05:30 EDT 2025
Tue Jul 01 03:06:28 EDT 2025
Fri Feb 21 02:33:52 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Parkinson disease
Nuclear enriched assembly transcript 1
Neuronal apoptosis
NLRP3 inflammasome
Endogenous competing RNA
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-9a1adfb23986dcd21b97d6fe2560d9ef7dd531d1adcb31dd5fa14870f3e34d023
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8257-0837
PMID 32712773
PQID 2476372239
PQPubID 326248
PageCount 10
ParticipantIDs proquest_miscellaneous_2427523840
proquest_journals_2476372239
pubmed_primary_32712773
crossref_citationtrail_10_1007_s12031_020_01660_2
crossref_primary_10_1007_s12031_020_01660_2
springer_journals_10_1007_s12031_020_01660_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210200
2021-02-00
2021-Feb
20210201
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 2
  year: 2021
  text: 20210200
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Totowa
PublicationSubtitle MN
PublicationTitle Journal of molecular neuroscience
PublicationTitleAbbrev J Mol Neurosci
PublicationTitleAlternate J Mol Neurosci
PublicationYear 2021
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Balestrino, Schapira (CR2) 2018; 24
Haque, Akther, Jakaria, Kim, Azam, Choi (CR7) 2020; 35
Wu, Yao, Chen, Chen, Huang, Liu, Cai, Yuan, Hei (CR21) 2020; 876
Yan, Chen, Chen, Chen (CR25) 2018; 496
Wang, Zhao, Xu, Zhang, Wang, Mao, Zhu, Li, Jiang, Tan, Xie, Yang, Zhang (CR19) 2019; 76
Klec, Prinz, Pichler (CR10) 2019; 13
Seppi, Ray Chaudhuri (CR16) 2019; 34
Adriaens, Rambow (CR1) 2019; 25
Jankovic, Goodman, Safirstein, Marmon, Schenk, Koller, Zago, Ness, Griffith, Grundman, Soto, Ostrowitzki, Boess, Martin-Facklam, Quinn, Isaacson, Omidvar, Ellenbogen, Kinney (CR8) 2018; 75
Xiong, Sun, Guan, Luo, Chen, An, Wang, Wu (CR23) 2016; 263
Ding, Zhao, Qiao, Wu, Wang (CR4) 2019; 307
Peng, Liu, Wang, Liu, Fu, Ma, Li, Sun, Ji, Lu, Wan, Lu (CR12) 2019; 47
Xie, Zhou, Li, Duan (CR22) 2019; 708
Schenkman, Moore, Kohrt, Hall, Delitto, Comella, Josbeno, Christiansen, Berman, Kluger, Melanson, Jain, Robichaud, Poon, Corcos (CR15) 2018; 75
Reyes, Sackmann, Hoffmann, Svenningsson, Winkler, Ingelsson, Hallbeck (CR14) 2019; 138
Gustot, Gallea, Sarroukh, Celej, Ruysschaert, Raussens (CR6) 2015; 471
Boros, Maszlag-Török, Vécsei, Klivényi (CR3) 2020; 1730
Jiang, Cheng, Ren, Wang, Kang, Ding, Hou, Yang, Lin, Liang, Gao (CR9) 2019; 47
Nussbaum (CR11) 2017; 7
Qian, Ye, Mao, Yao, Sun, Wang, Zhang, Xie, Zhang, Zhang, Zhang, He (CR13) 2019; 384
Simchovitz, Hanan, Niederhoffer, Madrer, Yayon, Bennett, Greenberg, Kadener, Soreq (CR17) 2019; 33
CR27
CR26
Zhou, Lu, Du, Qiao, Jiang, Zhang, Ding, Hu (CR28) 2016; 11
CR20
Simchovitz, Hanan, Yayon, Lee, Bennett, Greenberg, Kadener, Soreq (CR18) 2020; 19
Gordon, Albornoz (CR5) 2018; 10
Xu, Zhuang, Wu, Qiu, Feng, Wu (CR24) 2018; 2018
R Balestrino (1660_CR2) 2018; 24
XM Ding (1660_CR4) 2019; 307
ME Haque (1660_CR7) 2020; 35
Y Zhou (1660_CR28) 2016; 11
C Qian (1660_CR13) 2019; 384
RL Nussbaum (1660_CR11) 2017; 7
C Adriaens (1660_CR1) 2019; 25
R Gordon (1660_CR5) 2018; 10
SP Xie (1660_CR22) 2019; 708
1660_CR20
X Xu (1660_CR24) 2018; 2018
M Schenkman (1660_CR15) 2018; 75
T Peng (1660_CR12) 2019; 47
J Jankovic (1660_CR8) 2018; 75
A Simchovitz (1660_CR18) 2020; 19
FA Boros (1660_CR3) 2020; 1730
K Seppi (1660_CR16) 2019; 34
Z Wang (1660_CR19) 2019; 76
1660_CR27
C Klec (1660_CR10) 2019; 13
S Wu (1660_CR21) 2020; 876
A Simchovitz (1660_CR17) 2019; 33
WX Xiong (1660_CR23) 2016; 263
A Gustot (1660_CR6) 2015; 471
S Jiang (1660_CR9) 2019; 47
JF Reyes (1660_CR14) 2019; 138
W Yan (1660_CR25) 2018; 496
1660_CR26
References_xml – volume: 13
  start-page: 46
  issue: 1
  year: 2019
  end-page: 60
  ident: CR10
  article-title: Involvement of the long noncoding RNA NEAT1 in carcinogenesis
  publication-title: Mol Oncol
  doi: 10.1002/1878-0261.12404
– volume: 1730
  start-page: 146672
  year: 2020
  ident: CR3
  article-title: Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2020.146672
– volume: 47
  start-page: 7842
  issue: 15
  year: 2019
  end-page: 7856
  ident: CR9
  article-title: An expanded landscape of human long noncoding RNA
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz621
– volume: 708
  start-page: 134340
  year: 2019
  ident: CR22
  article-title: NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2019.134340
– volume: 25
  start-page: 1681
  issue: 12
  year: 2019
  end-page: 1695
  ident: CR1
  article-title: The long noncoding RNA NEAT1_1 is seemingly dispensable for normal tissue homeostasis and cancer cell growth
  publication-title: RNA
  doi: 10.1261/rna.071456.119
– volume: 24
  start-page: 540
  issue: 5
  year: 2018
  end-page: 559
  ident: CR2
  article-title: Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications
  publication-title: Neuroscientist
  doi: 10.1177/1073858417748875
– volume: 263
  start-page: 1984
  issue: 10
  year: 2016
  end-page: 1992
  ident: CR23
  article-title: The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review
  publication-title: J Neurol
  doi: 10.1007/s00415-016-8213-1
– volume: 19
  issue: 3
  year: 2020
  ident: CR18
  article-title: A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra
  publication-title: Aging Cell
  doi: 10.1111/acel.13115
– volume: 35
  start-page: 20
  issue: 1
  year: 2020
  end-page: 33
  ident: CR7
  article-title: Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.27874
– volume: 496
  start-page: 1019
  issue: 4
  year: 2018
  end-page: 1024
  ident: CR25
  article-title: LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.12.149
– ident: CR27
– volume: 384
  start-page: 111614
  issue: 1
  year: 2019
  ident: CR13
  article-title: Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222 /p27/mTOR pathway in Parkinson's disease
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2019.111614
– volume: 2018
  start-page: 8181374
  year: 2018
  ident: CR24
  article-title: LincRNA-p21 inhibits cell viability and promotes cell apoptosis in Parkinson's disease through activating α-Synuclein expression
  publication-title: Biomed Res Int
– volume: 7
  start-page: S43
  issue: s1
  year: 2017
  end-page: s49
  ident: CR11
  article-title: The identification of alpha-Synuclein as the first Parkinson disease gene
  publication-title: J Park Dis
– volume: 75
  start-page: 219
  issue: 2
  year: 2018
  end-page: 226
  ident: CR15
  article-title: Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2017.3517
– volume: 471
  start-page: 323
  issue: 3
  year: 2015
  end-page: 333
  ident: CR6
  article-title: Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
  publication-title: Biochem J
  doi: 10.1042/BJ20150617
– volume: 76
  start-page: 3005
  issue: 15
  year: 2019
  end-page: 3018
  ident: CR19
  article-title: NEAT1 regulates neuroglial cell mediating Abeta clearance via the epigenetic regulation of endocytosis-related genes expression
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03074-9
– volume: 75
  start-page: 1206
  issue: 10
  year: 2018
  end-page: 1214
  ident: CR8
  article-title: Safety and tolerability of multiple ascending doses of PRX002/RG7935, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2018.1487
– volume: 34
  start-page: 180
  issue: 2
  year: 2019
  end-page: 198
  ident: CR16
  article-title: Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
  publication-title: Mov Disord
  doi: 10.1002/mds.27602
– volume: 876
  start-page: 173056
  year: 2020
  ident: CR21
  article-title: Connexin 32 deficiency protects the liver against ischemia/reperfusion injury
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173056
– volume: 10
  start-page: eaah4066
  issue: 465
  year: 2018
  ident: CR5
  article-title: Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aah4066
– volume: 33
  start-page: 11223
  issue: 10
  year: 2019
  end-page: 11234
  ident: CR17
  article-title: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress
  publication-title: FASEB J
  doi: 10.1096/fj.201900830R
– volume: 138
  start-page: 23
  issue: 1
  year: 2019
  end-page: 47
  ident: CR14
  article-title: Binding of alpha-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-019-02007-x
– volume: 11
  start-page: 28
  year: 2016
  ident: CR28
  article-title: MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-016-0094-3
– volume: 47
  start-page: 2764
  issue: 1
  year: 2019
  end-page: 2774
  ident: CR12
  article-title: Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation
  publication-title: Artif Cells Nanomed Biotechnol
  doi: 10.1080/21691401.2019.1636805
– ident: CR26
– ident: CR20
– volume: 307
  start-page: 73
  year: 2019
  end-page: 81
  ident: CR4
  article-title: Long non-coding RNA-p21 regulates MPP(+)-induced neuronal injury by targeting miR-625 and derepressing TRPM2 in SH-SY5Y cells
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2019.04.017
– volume: 47
  start-page: 2764
  issue: 1
  year: 2019
  ident: 1660_CR12
  publication-title: Artif Cells Nanomed Biotechnol
  doi: 10.1080/21691401.2019.1636805
– volume: 76
  start-page: 3005
  issue: 15
  year: 2019
  ident: 1660_CR19
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03074-9
– volume: 10
  start-page: eaah4066
  issue: 465
  year: 2018
  ident: 1660_CR5
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aah4066
– volume: 19
  issue: 3
  year: 2020
  ident: 1660_CR18
  publication-title: Aging Cell
  doi: 10.1111/acel.13115
– ident: 1660_CR20
  doi: 10.1007/s00018-020-03503-0
– ident: 1660_CR26
  doi: 10.1111/cpr.12329
– volume: 13
  start-page: 46
  issue: 1
  year: 2019
  ident: 1660_CR10
  publication-title: Mol Oncol
  doi: 10.1002/1878-0261.12404
– volume: 75
  start-page: 1206
  issue: 10
  year: 2018
  ident: 1660_CR8
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2018.1487
– volume: 24
  start-page: 540
  issue: 5
  year: 2018
  ident: 1660_CR2
  publication-title: Neuroscientist
  doi: 10.1177/1073858417748875
– volume: 7
  start-page: S43
  issue: s1
  year: 2017
  ident: 1660_CR11
  publication-title: J Park Dis
– volume: 11
  start-page: 28
  year: 2016
  ident: 1660_CR28
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-016-0094-3
– ident: 1660_CR27
  doi: 10.1007/s10620-019-06020-8
– volume: 35
  start-page: 20
  issue: 1
  year: 2020
  ident: 1660_CR7
  publication-title: Mov Disord
  doi: 10.1002/mds.27874
– volume: 384
  start-page: 111614
  issue: 1
  year: 2019
  ident: 1660_CR13
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2019.111614
– volume: 263
  start-page: 1984
  issue: 10
  year: 2016
  ident: 1660_CR23
  publication-title: J Neurol
  doi: 10.1007/s00415-016-8213-1
– volume: 471
  start-page: 323
  issue: 3
  year: 2015
  ident: 1660_CR6
  publication-title: Biochem J
  doi: 10.1042/BJ20150617
– volume: 75
  start-page: 219
  issue: 2
  year: 2018
  ident: 1660_CR15
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2017.3517
– volume: 876
  start-page: 173056
  year: 2020
  ident: 1660_CR21
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173056
– volume: 2018
  start-page: 8181374
  year: 2018
  ident: 1660_CR24
  publication-title: Biomed Res Int
– volume: 33
  start-page: 11223
  issue: 10
  year: 2019
  ident: 1660_CR17
  publication-title: FASEB J
  doi: 10.1096/fj.201900830R
– volume: 47
  start-page: 7842
  issue: 15
  year: 2019
  ident: 1660_CR9
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz621
– volume: 1730
  start-page: 146672
  year: 2020
  ident: 1660_CR3
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2020.146672
– volume: 496
  start-page: 1019
  issue: 4
  year: 2018
  ident: 1660_CR25
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.12.149
– volume: 25
  start-page: 1681
  issue: 12
  year: 2019
  ident: 1660_CR1
  publication-title: RNA
  doi: 10.1261/rna.071456.119
– volume: 138
  start-page: 23
  issue: 1
  year: 2019
  ident: 1660_CR14
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-019-02007-x
– volume: 708
  start-page: 134340
  year: 2019
  ident: 1660_CR22
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2019.134340
– volume: 307
  start-page: 73
  year: 2019
  ident: 1660_CR4
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2019.04.017
– volume: 34
  start-page: 180
  issue: 2
  year: 2019
  ident: 1660_CR16
  publication-title: Mov Disord
  doi: 10.1002/mds.27602
SSID ssj0021418
Score 2.4201827
Snippet Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased...
Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 369
SubjectTerms 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology
alpha-Synuclein - physiology
Apoptosis
Apoptosis - drug effects
Apoptosis Regulatory Proteins - biosynthesis
Apoptosis Regulatory Proteins - genetics
Biomedical and Life Sciences
Biomedicine
Cell Biology
Cell Line
Connexins - biosynthesis
Connexins - genetics
Disease Progression
Down-Regulation
Gap Junction beta-1 Protein
Gene Expression Regulation - drug effects
Gene Knockdown Techniques
Humans
Inflammasomes
Inflammasomes - physiology
MicroRNAs - antagonists & inhibitors
MicroRNAs - genetics
Movement disorders
MPP
Neurochemistry
Neurodegenerative diseases
Neurology
Neurons - drug effects
Neurons - metabolism
Neurosciences
NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors
NLR Family, Pyrin Domain-Containing 3 Protein - biosynthesis
NLR Family, Pyrin Domain-Containing 3 Protein - genetics
Non-coding RNA
Parkinson Disease - genetics
Parkinson's disease
Proteomics
RNA, Long Noncoding - biosynthesis
RNA, Long Noncoding - genetics
Signal Transduction
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NTtwwEB4VeuGCaCkQSitXQr2ARewkdnyqVgWEKhWhFqQ9ETm2IyFBdtsslbjxGn29PklnnOyuKlROOayzsWY8nv9vAPZ1USupm5xnMi3QQSktt40QPAS8JnPlShchNr6eq7Or_Mu4GA8Bt24oq5zfifGi9hNHMfIjmaMkaFRm5tP0B6epUZRdHUZorMBLgi6jki49XjpcIo_xvbQ0BS-VUUPTTN86J_E4c3Ke0OhRKZf_KqYn1uaTTGlUQKcbsD5YjmzUs_oVvAjta9gcteg13z2wjyzWcsYg-SZcn5-MLgU7jjYhRQMYTe-MOOEdo0bn2PP15_F3x477DA27oEKtHqSD_bqxbOSoIJrZjt3dfOOogwTPpuz7dIJ7ewNXpyeXn8_4MEmBu0wXM26ssL6pCetPeeelqI32qglk73gTGu09yqLHRa7Gpy8ai26STpssZLlHtb4Fq-2kDTvA0JwpVHCNSI3PtSnqMtQl3gQW2ayVyRMQczJWboAZp2kXt9USIJlIXyHpq0j6SiZwsHhn2oNsPLt6b86dahC4rloejwQ-LH5GUaH8h23D5J7WSI1-N7q0CWz3XF18LpNaSK2zBA7nbF7--f_3svv8Xt7CmqQamFjlvQers5_34R0aMbP6fTypfwGef-mP
  priority: 102
  providerName: ProQuest
Title NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge
URI https://link.springer.com/article/10.1007/s12031-020-01660-2
https://www.ncbi.nlm.nih.gov/pubmed/32712773
https://www.proquest.com/docview/2476372239
https://www.proquest.com/docview/2427523840
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB5Be-GCCuUntKyMhLiApdiJ7fiYpbtUIFZV6UrLhciJHakSza6abaXe-hq8Hk_C2El2hQpInHyI40QznplvPD8GeK1EKbmqU5rwWKCDkhlqasaoc6gmU1llVWix8Xkmj-fpx4VY9EVh7ZDtPoQkg6beFrtx3IDUuzsIU2RMUfHuCu-74y6e83zjZrE0nOrFmRY0k1r2pTJ_XuN3c3QHY96JjwazM92Dhz1eJHnH4EdwzzWPYT9v0Fe-uCFvSMjgDEfj-_BtNsnPGDkKSNCfARB_Z2foDt4SX94cKr1-3v5oyVEXlyEnPj2ra81Brs8NySufBk1MSy7OTylaHkaTFfmyWuK_PYH5dHL2_pj29yfQKlFiTbVhxtal7_AnbWU5K7WysnYe5VjtamUtSqDFSVWJoxW1QedIxXXiktSiMX8KO82ycc-BIIgR0lU1i7VNlRZl5soM5d8gc5XUaQRsIGNR9c3F_R0X34ttW2RP-gJJXwTSFzyCt5t3Vl1rjX_OPhy4U_Ri1hY8RfWoEOHoCF5tHqOA-KiHadzyys_hCr1tdGQjeNZxdfO5hCvGlUoieDewebv43__lxf9NP4AH3GfChFzvQ9hZX165lwhl1uUI7quFGsFuPh2PZ3788PXTBMfxZHZyOgr7-hfLQOvX
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB5V2wNcUEv5CS1gJOACFrHj2PEBoYXdakvbVVW2Uk-EJHakSm1222xBvfEavAQPxZMwdpJdoYreesphnY01nr9vPD8AL1WcS65KQSMexghQkoxmJWPUWlSTQhZJ4Vts7I_l6Eh8Po6PV-B3Vwvj0io7negVtZkWLkb-jguUBIXGTH-YnVM3NcrdrnYjNBq22LVXPxCy1e93Bni-rzjfHk4-jWg7VYAWkYrnVGcsM2Xu-t5JUxjOcq2MLK2z_UbbUhmDfGlwUZHj08RlhpBBhWVkI2F8owNU-asiQijTg9WPw_HB4QLiMeEjimGiY5pILdsynaZYj6MAUQfX0M2SIeX_msJr_u21u1lv8rbX4F7rq5J-w1zrsGKr-7DRrxCnn12R18Rnj_qw_AZ8HQ_7E0YG3gt18Qfi5oX6zuQ1caXVvsrsz89fNRk0d0LkwKWGNW1ByPeTjPQLl4JNspqcnRxStHqMRjPyZTbFvT2Ao1uh8kPoVdPKPgaCDlQsbVGyUBuhdJwnNk9Q92TIWEpqEQDryJgWbWNzN1_jNF22ZHakT5H0qSd9ygN4s3hn1rT1uHH1Vnc6aSvidbpkyABeLH5G4XQ3Llllp5duDVeI9BFEB_CoOdXF5yKuGFcqCuBtd8zLP___Xp7cvJfncGc02d9L93bGu5twl7sMHJ9jvgW9-cWlfYou1Dx_1vItgW-3LSp_AaQtKXc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRA9FAqiC9SrZfYVkdQX3RoZpLMZB5EFrdLa3Up2sI-GZO5QKHNbs3W0jd_w1_xc_wSz0ySXaTYtz7lYSeb4dzvB-CFzCrBpUtpwuMMHZS8pKVjjFqLYjIVOtdhxMansdg9Sj9MsskK_O57YXxZZS8Tg6A2U-1j5Ns8RU6QqMzUtuvKIg6Go3ezM-o3SPlMa79OoyWRfXt5ge5b83ZviLh-yflo5_D9Lu02DFCdyGxOVclK4yo_A08YbTirlDTCWW8HGGWdNAZp1OAhXeHTZK5E90HGLrFJasLQAxT_t2SSMc9jcrJ09lgaYotxrjKaCyW6hp22bY8jK1HvuKHBJWLK_1WKVyzdK1naoPxGa3C3s1rJoCWze7Bi6_uwPqjRYz-9JK9IqCMNAfp1-DreGRwyMgz2qI9EEL85NMwob4hvsg79Zn9-_mrIsM0OkQNfJNYOCCE_jksy0L4Ym5QNOT3-TFH_MZrMyJfZFO_2AI5uBMYPYbWe1vYxEDSlMmG1Y7EyqVRZldsqRylUIolJodIIWA_GQncjzv2mjZNiOZzZg75A0BcB9AWP4PXinVk74OPa05s9doqO2ZtiSZoRPF_8jGzqcy9lbafn_gyX6POjOx3Boxari88lXDIuZRLBmx7Nyz___12eXH-XZ3AbGaT4uDfe34A73JfihGLzTVidfz-3W2hLzaungWgJfLtpLvkLdQYsRw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NEAT1+Decreasing+Suppresses+Parkinson%E2%80%99s+Disease+Progression+via+Acting+as+miR-1301-3p+Sponge&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Sun%2C+Qiang&rft.au=Zhang%2C+Yueliang&rft.au=Wang%2C+Songlin&rft.au=Yang%2C+Fang&rft.date=2021-02-01&rft.pub=Springer+US&rft.issn=0895-8696&rft.eissn=1559-1166&rft.volume=71&rft.issue=2&rft.spage=369&rft.epage=378&rft_id=info:doi/10.1007%2Fs12031-020-01660-2&rft.externalDocID=10_1007_s12031_020_01660_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8696&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8696&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8696&client=summon